Physician

Abiy Kelil, M.D.

According to 2025 Medicare claims, Abiy Kelil, M.D. (NPI: 1295935096) practices critical care (intensivists) in the Parkersburg-Vienna, WV market, with the plurality of this provider's patient population coming from Wood, WV. This provider's primary affiliated billing organization is CAMDEN-CLARK PHYSICIAN CORPORATION (NPI: 1710125430; TIN: 264058719) and primary practice location at 26101-0718. Kelil is affiliated with the ACO West Virginia (ACO ID: A3563), participating under the MSSP model.

Kelil's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 735 traditional Medicare patients, billed 2,018 HCPCS/CPT codes, and received $161,925 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). Part D data shows 3,322 prescription claims across 699 beneficiaries totaling $1,896,684 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 2,052 claims. Open Payments data shows 7 records totaling $119. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $500 to $1,896,684. For DME billing, reported payments rose steadily, from $1,349 to $149,141.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	415	1,630	$205,205
2016	710	2,638	$253,242
2017	779	2,558	$177,130
2018	861	2,665	$203,451
2019	994	3,185	$241,889
2020	817	2,577	$239,380
2021	703	2,212	$205,009
2022	620	1,842	$145,218
2023	610	1,623	$123,744
2024	735	2,018	$161,925

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	12	$500
2016	29	56	$9,666
2017	180	632	$150,337
2018	322	1,324	$357,641
2019	351	1,391	$471,993
2020	320	1,223	$423,267
2021	253	917	$413,540
2022	307	1,142	$587,861
2023	575	2,531	$1,468,972
2024	699	3,322	$1,896,684

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	40	358	$25,860
2018	238	937	$112,125
2019	394	1,677	$175,255
2020	402	1,462	$164,401
2021	283	1,347	$156,735
2022	291	1,254	$140,934
2023	440	1,643	$174,507
2024	635	2,052	$162,844

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99291	Critical care, first 30-74 minutes	112	297	$169
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	110	226	$92
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	307	438	$72
94060	Test to measure expiratory airflow and volume changes before and after medication administration	114	115	$8
94729	Test to examine how well the lungs exchange gases	118	119	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	451	20,370	$428,700
Ofev	Nintedanib Esylate	20	600	$261,534
Prolastin C	Alpha-1-Proteinase Inhibitor	25	679	$228,506
Dupixent Pen	Dupilumab	32	882	$116,797
Aralast Np	Alpha-1-Proteinase Inhibitor	21	588	$112,962

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	44	$44,255
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	48	352	$28,883
E0483	High frequency chest wall oscillation system, with full anterior and/or posterior thoracic region receiving simultaneous external oscillation, includes all accessories and supplies, each	Y	N/R	25	$18,335
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	13	$9,920
E0601	Continuous positive airway pressure (cpap) device	Y	40	223	$8,386

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$119	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abiy Kelil, M.D.?

Tedicare shows public-source Medicare data for Abiy Kelil, M.D. (NPI 1295935096), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abiy Kelil, M.D. have ACO affiliation data?

Abiy Kelil, M.D. is shown with ACO affiliation data for ACO West Virginia (MSSP, ACO ID A3563).

What billing organization is linked to Abiy Kelil, M.D.?

Abiy Kelil, M.D. is linked to CAMDEN-CLARK PHYSICIAN CORPORATION (billing NPI 1710125430) in the available physician profile data.

Does Abiy Kelil, M.D. have Open Payments data?

Abiy Kelil, M.D. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.